Annual CFI
-$105.70 K
+$13.57 M+99.23%
December 31, 2023
Summary
- As of February 8, 2025, CPIX annual cash flow from investing activities is -$105.70 thousand, with the most recent change of +$13.57 million (+99.23%) on December 31, 2023.
- During the last 3 years, CPIX annual CFI has risen by +$1.65 million (+93.99%).
- CPIX annual CFI is now -101.11% below its all-time high of $9.51 million, reached on December 31, 2017.
Performance
CPIX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$189.60 K
+$236.40 K+505.13%
September 30, 2024
Summary
- As of February 8, 2025, CPIX quarterly cash flow from investing activities is $189.60 thousand, with the most recent change of +$236.40 thousand (+505.13%) on September 30, 2024.
- Over the past year, CPIX quarterly CFI has dropped by -$71.00 thousand (-27.24%).
- CPIX quarterly CFI is now -97.27% below its all-time high of $6.94 million, reached on September 30, 2019.
Performance
CPIX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$345.20 K
+$284.70 K+470.58%
September 30, 2024
Summary
- As of February 8, 2025, CPIX TTM cash flow from investing activities is $345.20 thousand, with the most recent change of +$284.70 thousand (+470.58%) on September 30, 2024.
- Over the past year, CPIX TTM CFI has increased by +$451.00 thousand (+426.28%).
- CPIX TTM CFI is now -96.37% below its all-time high of $9.51 million, reached on December 31, 2017.
Performance
CPIX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CPIX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +99.2% | -27.2% | +426.3% |
| 3 y3 years | +94.0% | +275.2% | +143.6% |
| 5 y5 years | +99.6% | -90.0% | -85.0% |
CPIX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +99.2% | -72.2% | +101.4% | at high | +102.5% |
| 5 y | 5-year | -104.6% | +99.2% | -90.0% | +101.4% | -95.7% | +102.5% |
| alltime | all time | -101.1% | +99.6% | -97.3% | +100.9% | -96.4% | +101.3% |
Cumberland Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $189.60 K(-505.1%) | $345.20 K(+470.6%) |
| Jun 2024 | - | -$46.80 K(-19.6%) | $60.50 K(+476.2%) |
| Mar 2024 | - | -$58.20 K(-122.3%) | $10.50 K(-109.9%) |
| Dec 2023 | -$105.70 K(-99.2%) | $260.60 K(-374.0%) | -$105.80 K(-89.5%) |
| Sep 2023 | - | -$95.10 K(-1.8%) | -$1.01 M(+335.5%) |
| Jun 2023 | - | -$96.80 K(-44.5%) | -$231.30 K(-24.7%) |
| Mar 2023 | - | -$174.50 K(-72.8%) | -$307.10 K(-97.8%) |
| Dec 2022 | -$13.67 M(+2624.5%) | -$640.80 K(-194.1%) | -$13.67 M(+4.7%) |
| Sep 2022 | - | $680.80 K(-494.4%) | -$13.06 M(-5.7%) |
| Jun 2022 | - | -$172.60 K(-98.7%) | -$13.85 M(+0.9%) |
| Mar 2022 | - | -$13.54 M(>+9900.0%) | -$13.73 M(+2635.2%) |
| Dec 2021 | -$501.90 K(-71.4%) | -$26.80 K(-75.2%) | -$501.80 K(-36.6%) |
| Sep 2021 | - | -$108.20 K(+123.1%) | -$791.00 K(-41.5%) |
| Jun 2021 | - | -$48.50 K(-84.8%) | -$1.35 M(-10.2%) |
| Mar 2021 | - | -$318.30 K(+0.7%) | -$1.50 M(-14.4%) |
| Dec 2020 | -$1.76 M(-176.5%) | -$316.00 K(-52.8%) | -$1.76 M(-481.2%) |
| Sep 2020 | - | -$668.80 K(+231.3%) | $461.20 K(-94.3%) |
| Jun 2020 | - | -$201.90 K(-64.7%) | $8.07 M(+134.0%) |
| Mar 2020 | - | -$571.20 K(-130.0%) | $3.45 M(+50.1%) |
| Dec 2019 | $2.30 M(-108.3%) | $1.90 M(-72.6%) | $2.30 M(-110.9%) |
| Sep 2019 | - | $6.94 M(-243.9%) | -$21.02 M(-10.7%) |
| Jun 2019 | - | -$4.82 M(+179.9%) | -$23.53 M(+31.3%) |
| Mar 2019 | - | -$1.72 M(-92.0%) | -$17.93 M(-35.3%) |
| Dec 2018 | -$27.72 M(-391.5%) | -$21.41 M(-583.9%) | -$27.72 M(+715.2%) |
| Sep 2018 | - | $4.42 M(+463.9%) | -$3.40 M(+110.9%) |
| Jun 2018 | - | $784.60 K(-106.8%) | -$1.61 M(+2.1%) |
| Mar 2018 | - | -$11.52 M(-495.7%) | -$1.58 M(-116.6%) |
| Dec 2017 | $9.51 M(-405.4%) | $2.91 M(-53.1%) | $9.51 M(+86.3%) |
| Sep 2017 | - | $6.21 M(+660.5%) | $5.11 M(-413.3%) |
| Jun 2017 | - | $817.00 K(-290.2%) | -$1.63 M(-37.1%) |
| Mar 2017 | - | -$429.50 K(-71.3%) | -$2.59 M(-16.8%) |
| Dec 2016 | -$3.12 M(+32.8%) | -$1.50 M(+186.4%) | -$3.12 M(+59.1%) |
| Sep 2016 | - | -$522.00 K(+261.7%) | -$1.96 M(+40.9%) |
| Jun 2016 | - | -$144.30 K(-84.9%) | -$1.39 M(-34.6%) |
| Mar 2016 | - | -$953.50 K(+181.6%) | -$2.12 M(-9.4%) |
| Dec 2015 | -$2.35 M | -$338.60 K(-826.6%) | -$2.35 M(-33.4%) |
| Sep 2015 | - | $46.60 K(-105.3%) | -$3.52 M(-18.5%) |
| Jun 2015 | - | -$879.10 K(-25.1%) | -$4.32 M(-15.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | -$1.17 M(-22.4%) | -$5.14 M(-14.9%) |
| Dec 2014 | -$6.03 M(+19.0%) | -$1.51 M(+100.8%) | -$6.03 M(+40.7%) |
| Sep 2014 | - | -$753.30 K(-55.6%) | -$4.29 M(+5.8%) |
| Jun 2014 | - | -$1.70 M(-18.2%) | -$4.05 M(+5.5%) |
| Mar 2014 | - | -$2.07 M(-988.0%) | -$3.84 M(-24.3%) |
| Dec 2013 | -$5.07 M(-73.6%) | $233.40 K(-145.2%) | -$5.07 M(+23.5%) |
| Sep 2013 | - | -$516.70 K(-65.2%) | -$4.11 M(-18.8%) |
| Jun 2013 | - | -$1.48 M(-55.1%) | -$5.06 M(-19.4%) |
| Mar 2013 | - | -$3.31 M(-375.9%) | -$6.28 M(-67.3%) |
| Dec 2012 | -$19.18 M(+4280.3%) | $1.20 M(-181.7%) | -$19.18 M(-6.1%) |
| Sep 2012 | - | -$1.47 M(-45.8%) | -$20.43 M(+6.4%) |
| Jun 2012 | - | -$2.70 M(-83.3%) | -$19.20 M(+15.7%) |
| Mar 2012 | - | -$16.21 M(>+9900.0%) | -$16.59 M(+3690.2%) |
| Dec 2011 | -$437.80 K(-43.0%) | -$55.50 K(-75.9%) | -$437.70 K(-38.1%) |
| Sep 2011 | - | -$230.10 K(+135.8%) | -$707.50 K(-0.9%) |
| Jun 2011 | - | -$97.60 K(+79.1%) | -$713.70 K(-6.0%) |
| Mar 2011 | - | -$54.50 K(-83.2%) | -$759.10 K(-1.2%) |
| Dec 2010 | -$768.60 K(+7.9%) | -$325.30 K(+37.7%) | -$768.70 K(-13.2%) |
| Sep 2010 | - | -$236.30 K(+65.2%) | -$885.10 K(+10.8%) |
| Jun 2010 | - | -$143.00 K(+123.1%) | -$799.10 K(+7.3%) |
| Mar 2010 | - | -$64.10 K(-85.5%) | -$744.60 K(+4.5%) |
| Dec 2009 | -$712.30 K(+431.2%) | -$441.70 K(+193.9%) | -$712.40 K(+153.3%) |
| Sep 2009 | - | -$150.30 K(+69.8%) | -$281.20 K(+77.4%) |
| Jun 2009 | - | -$88.50 K(+177.4%) | -$158.50 K(+32.2%) |
| Mar 2009 | - | -$31.90 K(+203.8%) | -$119.90 K(-10.6%) |
| Dec 2008 | -$134.10 K(-18.0%) | -$10.50 K(-62.0%) | -$134.10 K(-35.9%) |
| Sep 2008 | - | -$27.60 K(-44.7%) | -$209.10 K(-3.8%) |
| Jun 2008 | - | -$49.90 K(+8.2%) | -$217.40 K(+22.3%) |
| Mar 2008 | - | -$46.10 K(-46.1%) | -$177.80 K(+8.7%) |
| Dec 2007 | -$163.50 K(-97.5%) | -$85.50 K(+138.2%) | -$163.50 K(+72.1%) |
| Sep 2007 | - | -$35.90 K(+248.5%) | -$95.00 K(+7.7%) |
| Jun 2007 | - | -$10.30 K(-67.6%) | -$88.20 K(-98.7%) |
| Mar 2007 | - | -$31.80 K(+87.1%) | -$6.54 M(-0.2%) |
| Dec 2006 | -$6.55 M(+1957.4%) | -$17.00 K(-41.6%) | -$6.55 M(+0.3%) |
| Sep 2006 | - | -$29.10 K(-99.5%) | -$6.54 M(+0.4%) |
| Jun 2006 | - | -$6.46 M(>+9900.0%) | -$6.51 M(>+9900.0%) |
| Mar 2006 | - | -$43.20 K | -$43.20 K |
| Dec 2005 | -$318.50 K | - | - |
FAQ
- What is Cumberland Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals annual CFI year-on-year change?
- What is Cumberland Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly CFI year-on-year change?
- What is Cumberland Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals TTM CFI year-on-year change?
What is Cumberland Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of CPIX is -$105.70 K
What is the all time high annual CFI for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high annual cash flow from investing activities is $9.51 M
What is Cumberland Pharmaceuticals annual CFI year-on-year change?
Over the past year, CPIX annual cash flow from investing activities has changed by +$13.57 M (+99.23%)
What is Cumberland Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of CPIX is $189.60 K
What is the all time high quarterly CFI for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high quarterly cash flow from investing activities is $6.94 M
What is Cumberland Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, CPIX quarterly cash flow from investing activities has changed by -$71.00 K (-27.24%)
What is Cumberland Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of CPIX is $345.20 K
What is the all time high TTM CFI for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high TTM cash flow from investing activities is $9.51 M
What is Cumberland Pharmaceuticals TTM CFI year-on-year change?
Over the past year, CPIX TTM cash flow from investing activities has changed by +$451.00 K (+426.28%)